Pathological findings in human autoimmune lymphoproliferative syndrome - Wikidata - wikimedia - TriplyDB

Pathological findings in human autoimmune lymphoproliferative syndrome

Pathological findings in human autoimmune lymphoproliferative syndrome

http://www.wikidata.org/entity/Q35754536

about

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop How I treat autoimmune lymphoproliferative syndrome Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Cervical lymph node diseases in children Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis Causes and consequences of the autoimmune lymphoproliferative syndrome Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.Fas/Fas ligand-mediated apoptosis in different cell lineages and functional compartments of human lymph nodes Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.ALPS-ten lessons from an international workshop on a genetic disease of apoptosis Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds.Autoimmune lymphoproliferative syndrome type III: an indefinite disorder.Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.Perforin: more than just a pore-forming protein.Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy.Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.Immune disorders caused by defects in the caspase cascade.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.The expanding spectrum of the autoimmune lymphoproliferative syndromes Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells Disorders of apoptosis: mechanisms for autoimmunity in primary immunodeficiency diseases.Genetic defects of apoptosis and primary immunodeficiency.Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations Benign non-infectious causes of lymphadenopathy: A review of cytomorphology and differential diagnosis.Progressive transformation of germinal centers in children and adolescents: an intriguing cause of lymphadenopathy.Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group.Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.Restimulation-induced cell death: new medical and research perspectives.T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing.Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.

P2860

Q24623371-AA4B48D5-D26D-4425-81C5-61728BB15F04 Q24632569-34826F41-CC29-437D-ADEF-354471D3692D Q24633207-94A2623A-1C53-4924-9582-5190C9158544 Q24643047-49A981B0-469A-4EBD-8D12-AEABADD011F5 Q26865114-24374F50-9DC9-403F-B1DD-38637C888384 Q28210645-9221431B-20F2-4F44-9D26-1279863F854F Q28239313-0768BE50-879C-41CC-A9F8-F4C3AA24018E Q28263161-8D0C6AA8-FFBE-45CB-8121-E207364AAC07 Q28264600-39BF27D6-F8F2-4763-8682-2DCC6E8D4158 Q28300792-9765F393-5132-4D6D-8254-50BE4A66B750 Q33343068-A519520B-C186-494B-B406-3A4428EBFFDC Q33375938-8020B213-742E-4886-911C-5BFE47159BC1 Q33579574-065A2BD9-20DC-4561-89AC-BABF717C44B9 Q33751250-1EA3E187-8E94-44D7-93CF-00C52618C0C8 Q33807422-A29E9EB3-2C67-4DDE-9E4C-D66685163BFA Q33944255-3C2BEABC-9425-4C02-ACA1-918A0D213FA2 Q34166328-F341DAAB-16E9-4DB8-9BBD-49BB5B402CAC Q34244530-B8BE6600-57E5-4269-A4C5-C7F971CA62F4 Q34265242-D7B4C55B-27E8-4DAF-854E-85CA4CF0B9E8 Q34513178-9CA16831-EB7B-49A3-9A59-3DC1A78ED540 Q34564711-D24DB335-4321-4726-849B-2379135925E3 Q34616180-85D3B3D2-3939-4EB0-9C81-7A3A4F8F3287 Q34698814-EED392CE-0C46-4022-8EB8-1B78479164FD Q35132088-BA93547C-A321-46DB-9D97-4B955DAE4E63 Q35195215-2F14BC3B-F60B-4464-AC77-E59A86B72DF1 Q35209364-E5705911-9E3C-42A5-ACE6-AD80D352FDA4 Q35619447-49AE3585-4090-45E8-8711-AD17C4BA74C1 Q35856318-BC7BD3C7-F0EE-4662-8C38-0E3E44215269 Q37056318-087F8E2C-1A94-4CD4-B47A-9660750618BB Q37142878-CAEBBA0B-5F28-4F04-AEC8-E4C9C157D761 Q37219274-6E8CBF62-8A10-4EBF-8CB6-51A4CFDEC0FB Q37618832-9C14E52C-5524-4FAF-8131-87124D0AA53E Q37670054-828C244B-3135-48A7-A7C3-C9AAB5797AEA Q37986725-75AED313-3478-4CA0-A553-9ACD8DCAAC19 Q38019441-FCB3CFE3-9CC3-4475-81E9-4ADC453C483E Q39098289-FF22196F-864B-4B9F-98E6-DB36E3D79E02 Q39232124-AFEB3140-93BD-4E08-BD6D-8F677878E925 Q39277444-5AF8BFD3-BADD-4469-8923-A1549EB08814 Q40202981-90F312E0-D80B-4C94-848B-2CB8C1539234 Q40323055-C07B15E9-3F55-4BEA-B4F0-79981989A323

P2860

Pathological findings in human autoimmune lymphoproliferative syndrome

http://www.wikidata.org/entity/Q35754536

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Pathological findings in human autoimmune lymphoproliferative syndrome

@ast

Pathological findings in human autoimmune lymphoproliferative syndrome

@en

type

label

Pathological findings in human autoimmune lymphoproliferative syndrome

@ast

Pathological findings in human autoimmune lymphoproliferative syndrome

@en

prefLabel

Pathological findings in human autoimmune lymphoproliferative syndrome

@ast

Pathological findings in human autoimmune lymphoproliferative syndrome

@en

P1433

Q35754536-79596B3D-8583-4B7B-9E74-80F218624CF9

P1476

Q35754536-5E665C8E-F0DA-465D-AAF3-3452F989C00E

P2093

Q35754536-0AE7E647-DA3E-4541-8C16-BC6FEE73724D

Q35754536-29DCF94E-3DB3-416E-9311-3308175B5BE4

Q35754536-2C829365-8632-4695-AA39-53FD4BE44C27

Q35754536-3149FED5-C7A3-4B96-BDAC-96FC6C4B4B76

Q35754536-5C910234-53C4-4367-B153-3D3008FC0D27

Q35754536-A321EA1D-DDC4-4FB5-BC6A-71FB9F9EC3C7

Q35754536-B260C414-E2FF-4695-A0EF-2FD46861C4C1

Q35754536-E1C2E80F-C1AB-41DC-84B4-55BF2D3601B9

Q35754536-E1DEF45A-FE03-467B-9373-F23A84032FB9

Q35754536-E2221E8F-E494-4D44-8CE0-263DA80335DD

P2860

Q35754536-05B136BA-22CE-4FA9-85C3-1EACBA8DF957

Q35754536-08216F1C-95D3-42B4-A86F-10C947A0BF68

Q35754536-2FFB1F24-5F41-44B3-B37D-6B3E9AEB42D8

Q35754536-32D4A892-20F9-4351-9C63-4D7CEC261A5F

Q35754536-54888B22-D94B-442F-9197-C7131594657C

Q35754536-55A39668-F1DC-4B84-B3F2-63665BD05FB4

Q35754536-60BD88E8-A7E7-4898-91B7-EBD7F76DEDF1

Q35754536-7346C3A2-3140-4A14-A82C-02EB6872E0C0

Q35754536-772705D0-4FF2-4574-B5A7-516F9EB73166

Q35754536-984AC9E1-C268-4D2D-8762-5557587C12CA

P304

Q35754536-F86032A7-BEE5-44E8-BC5E-E6BBAE2884A8

P31

Q35754536-31C15B92-7647-4F5A-B9C1-902C112A776E

P356

Q35754536-48E46BBB-8753-4A3C-9EBB-568FCA98FE35

P407

Q35754536-41A3E263-B08C-4FF8-8F60-A755A8FCAC68

P433

Q35754536-EB0D61A6-CB11-4DEC-92F1-B5755B4377AD

P478

Q35754536-805BFF04-16A9-4E8A-A6E6-DA22F88D0E6F

P50

Q35754536-1A50525C-908A-4B87-8A51-677A4329D746

Q35754536-716ED09E-57C3-45EF-A35E-88F5B2A64D88

P577

Q35754536-04FC8C2D-348F-4450-90AA-7ED4CBBE2AC4

P698

Q35754536-1C873687-9775-4460-8980-C4119F7CA97E

P921

Q35754536-16796729-694D-4D15-BA46-5BB7E6F9D3F2

P932

Q35754536-E57F23C5-F71C-485D-844E-69300A0C4DBF

P356

S0002-9440(10)65742-2

P1433

The American Journal of Pathology

P1476

Pathological findings in human autoimmune lymphoproliferative syndrome

@en

P2093

A Y Lin

http://www.w3.org/2001/XMLSchema#string

E S Jaffe

http://www.w3.org/2001/XMLSchema#string

J K Dale

http://www.w3.org/2001/XMLSchema#string

J M Puck

http://www.w3.org/2001/XMLSchema#string

M C Sneller

http://www.w3.org/2001/XMLSchema#string

M J Lenardo

http://www.w3.org/2001/XMLSchema#string

M Raffeld

http://www.w3.org/2001/XMLSchema#string

M Stetler-Stevenson

http://www.w3.org/2001/XMLSchema#string

S E Straus

http://www.w3.org/2001/XMLSchema#string

T A Fleisher

http://www.w3.org/2001/XMLSchema#string

P2860

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Clinical, immunological, and pathological consequences of Fas-deficient conditions.

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.

Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.

Double-negative (CD4-CD8-) lymphocytes bearing T-cell receptor alpha and beta chains in normal human skin.

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

P304

1541-1550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)65742-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

Kojo Elenitoba-Johnson

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9811346

http://www.w3.org/2001/XMLSchema#string

P921

autoimmune lymphoproliferative syndrome

P932

1853411

http://www.w3.org/2001/XMLSchema#string